Publications by authors named "Antonella Rispoli"

Claim this Profile
I
Implementation of guideline-directed medical therapy in patients with heart failure with reduced ejection fraction (OpTIMa-HF Registry).
Stefania Paolillo, Christian Basile, Federica Marzano, Dario Bruzzese, Piergiuseppe Agostoni, Antonella Rispoli

ESC Heart Fail· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An explainable model for predicting Worsening Heart Failure based on genetic programming.
Valeria Visco, Antonio Robustelli, Francesco Loria, Antonella Rispoli, Francesca Palmieri

Comput Biol Med· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effects of Dapagliflozin in a real-world population of HFrEF patients with different hemodynamic profiles: worse is better.
Francesco Loria, Pasquale Mone, Antonella Rispoli, Rosanna Di Fonzo, Daniele Masarone

Cardiovasc Diabetol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The favourable alliance between CardioMEMS and levosimendan in patients with advanced heart failure.
Valeria Visco, Cristina Esposito, Antonella Rispoli, Paola Di Pietro, Carmine Izzo

ESC Heart Fail· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vitamin D: A Bridge between Kidney and Heart.
Carmine Secondulfo, Valeria Visco, Nicola Virtuoso, Martino Fortunato, Serena Migliarino, Antonella Rispoli

Life (Basel)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute heart failure: mechanisms and pre-clinical models-a Scientific Statement of the ESC Working Group on Myocardial Function.
Michele Ciccarelli, Inês Falcão Pires, Johann Bauersachs, Luc Bertrand, Christophe Beauloye, Antonella Rispoli

Cardiovasc Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Wearable Technologies and AI at the Far Edge for Chronic Heart Failure Prevention and Management: A Systematic Review and Prospects.
Angela-Tafadzwa Shumba, Teodoro Montanaro, Ilaria Sergi, Alessia Bramanti, Michele Ciccarelli, Antonella Rispoli

Sensors (Basel)· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Moving toward Precision Medicine in Acute Coronary Syndromes: A Multimodal Assessment of Non-Culprit Lesions.
Michele Bellino, Angelo Silverio, Luca Esposito, Francesco Paolo Cancro, Germano Junior Ferruzzi, Antonella Rispoli

J Clin Med· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Artificial Intelligence in Hypertension Management: An Ace up Your Sleeve.
Valeria Visco, Carmine Izzo, Costantino Mancusi, Antonella Rispoli, Michele Tedeschi

J Cardiovasc Dev Dis· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Implications of microRNAs in Coronavirus Disease 2019.
Carmine Izzo, Valeria Visco, Jessica Gambardella, Germano Junior Ferruzzi, Antonella Rispoli

J Pharmacol Exp Ther· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Untargeted lipidomics reveals specific lipid profiles in COVID-19 patients with different severity from Campania region (Italy).
Michele Ciccarelli, Fabrizio Merciai, Albino Carrizzo, Eduardo Sommella, Paola Di Pietro, Antonella Rispoli

J Pharm Biomed Anal· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Echocardiographically defined haemodynamic categorization predicts prognosis in ambulatory heart failure patients treated with sacubitril/valsartan.
Frank L Dini, Erberto Carluccio, Roberto Bitto, Michele Ciccarelli, Michele Correale, Antonella Rispoli

ESC Heart Fail· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit from sacubitril/valsartan is associated with hemodynamic improvement in heart failure with reduced ejection fraction: An echocardiographic study.
Erberto Carluccio, Frank L Dini, Roberto Bitto, Michele Ciccarelli, Michele Correale, Antonella Rispoli

Int J Cardiol· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-COVID-19 Syndrome: Involvement and Interactions between Respiratory, Cardiovascular and Nervous Systems.
Valeria Visco, Carolina Vitale, Antonella Rispoli, Carmine Izzo, Nicola Virtuoso

J Clin Med· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical and echocardiographic benefit of Sacubitril/Valsartan in a real-world population with HF with reduced ejection fraction.
Maria Vincenza Polito, Angelo Silverio, Antonella Rispoli, Gennaro Vitulano, Federica D' Auria

Sci Rep· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis